The EPA maintains an ongoing literature search process for the identification of relevant scientific studies published since the last review of the National Ambient Air Quality Standard (NAAQS) (U.S. EPA 2011) for each criteria pollutant, including the O 3 Integrated Science Assessment (ISA). For the identification of new studies, search strategies are designed for pollutants and scientific disciplines and iteratively modified to optimize identification of pertinent publications. For this search, the terms "ozone", "O 3 ", "smog", and "photochemical oxidant(s)" were used in both PubMed and Web of Science. In addition, studies were identified for inclusion in the ISA in several ways: specialized searches on specific topics; independent review of tables of contents for journals in which relevant papers may be published; identification of relevant literature by expert scientists; review of citations in previous assessments and identification by the public and the Clean Air Scientific Advisory Committee (CASAC) (U.S. EPA 2014) during the external review process. Additionally, during the process of developing the O 3 Integrated Science Assessment (ISA), scientific publications are provided to the Agency by the public through a call for information in the Federal Register (U.S. EPA, 2008).
These criteria provide benchmarks for evaluating various studies and for focusing on the policyrelevant studies in assessing the body of health effects evidence. Of most relevance for inclusion are studies that provide useful qualitative or quantitative information on O 3 exposure-effect or exposure-response relationships at doses or concentrations relevant to ambient conditions that can inform decisions on whether to retain or revise the standards. Therefore, concentrations above 2 ppm were excluded from the review.
The results from the large global search were reduced using exclusion criteria (e.g. non-English language and not related to ambient air, such as disinfection byproducts) and targeted searches for key health endpoints to 4,057 references that were considered for inclusion in the O 3 ISA. A total of 2,270 references deemed by EPA scientists to be of high quality, based on the above considerations, was included in the final document.
Evaluation of scientific evidence and the causal framew ork
To aid judgment in interpreting scientific results, various "aspects" of causality have been discussed by many philosophers and scientists. The "aspects" to judging causality developed by Sir Austin Bradford Hill (Hill 1965) formed the basis for EPA's causal determination framework, but was modified to encompass a broader array of data (Table S1), i.e., epidemiologic, controlled human exposure, ecological, and animal toxicological studies, as well as in vitro data, and to be more consistent with EPA's Guidelines for Carcinogen Risk Assessment (U.S. EPA 2009; U.S. EPA 2005) . Additionally this framework was developed to be specific to examining causality for health and welfare effects for pollutant exposures. Although these aspects provide a framework for assessing the evidence, they do not lend themselves to being considered in terms of simple formulas or fixed rules of the evidence necessary to lead to conclusions about causality (Hill 1965) . Rather, these aspects provide a framework for systematic appraisal of the body of evidence, informed by peer and public comment and advice, which includes weighing alternative views on controversial issues. In addition, it is important to note that the aspects presented in Table S1 cannot be used as a strict checklist, but rather to determine the weight of the evidence for inferring causality. In particular, not meeting one or more of the principles does not automatically preclude a determination of causality [see discussion in (CDC 2004) ]. Building off these aspects used to judge causality the US EPA developed a causal framework to draw conclusions regarding the causal relationship between relevant pollutant exposures and health or environmental effects as discussed in the O 3 ISA.
This weight of evidence approach is detailed in Table S2 . It is with these aspects in judging causality in mind that we modified the causality framework detailed in Table S2 to encompass examining response modifying factors, which is used to draw conclusions regarding whether a specific factor increases or decreases the risk of an air pollutant (i.e. O 3 )-related health effect. Table S1 . Table from the US EPA's Integrated Science Assessments, "Aspects to aid in judging causality."
Aspect Description

Consistency of the observed association
An inference of causality is strengthened when a pattern of elevated risks is observed across several independent studies. The reproducibility of findings constitutes one of the strongest arguments for causality. If there are discordant results among investigations, possible reasons such as differences in exposure, confounding factors, and the power of the study are considered.
Coherence
An inference of causality from one line of evidence (e.g., epidemiologic, clinical, or animal studies) may be strengthened by other lines of evidence that support a cause-and-effect interpretation of the association. Evidence on ecological or welfare effects may be drawn from a variety of experimental approaches (e.g., greenhouse, laboratory, and field) and subdisciplines of ecology (e.g., community ecology, biogeochemistry, and paleontological/historical reconstructions). The coherence of evidence from various fields greatly adds to the strength of an inference of causality. In addition, there may be coherence in demonstrating effects across multiple study designs or related health endpoints within one scientific line of evidence.
Biological plausibility.
An inference of causality tends to be strengthened by consistency with data from experimental studies or other sources demonstrating plausible biological mechanisms. A proposed mechanistic linking between an effect and exposure to the agent is an important source of support for causality, especially when data establishing the existence and functioning of those mechanistic links are available.
Biological gradient (exposure-response relationship)
A well-characterized exposure-response relationship (e.g., increasing effects associated with greater exposure) strongly suggests cause and effect, especially when such relationships are also observed for duration of exposure (e.g., increasing effects observed following longer exposure times).
Strength of the observed association
The finding of large, precise risks increases confidence that the association is not likely due to chance, bias, or other factors. However, it is noted that a small magnitude in an effect estimate may represent a substantial effect in a population.
Experimental evidence
Strong evidence for causality can be provided through "natural experiments" when a change in exposure is found to result in a change in occurrence or frequency of health or welfare effects.
Temporal relationship of the observed association
Evidence of a temporal sequence between the introduction of an agent, and appearance of the effect, constitutes another argument in favor of causality.
Specificity of the observed association
Evidence linking a specific outcome to an exposure can provide a strong argument for causation. However, it must be recognized that rarely, if ever, does exposure to a pollutant invariably predict the occurrence of an outcome, and that a given outcome may have multiple causes.
Analogy
Structure activity relationships and information on the agent's structural analogs can provide insight into whether an association is causal. Similarly, information on mode of action for a chemical, as one of many structural analogs, can inform decisions regarding likely causality. 
Health effects Causal relationship
Evidence is sufficient to conclude that there is a causal relationship with relevant pollutant exposures (i.e., doses or exposures generally within one to two orders of magnitude of current levels). That is, the pollutant has been shown to result in health effects in studies in which chance, bias, and confounding could be ruled out with reasonable confidence. For example: a) controlled human exposure studies that demonstrate consistent effects; or b) observational studies that cannot be explained by plausible alternatives or are supported by other lines of evidence (e.g., animal studies or mode of action information). Evidence includes multiple high-quality studies.
Likely to be a causal relationship
Evidence is sufficient to conclude that a causal relationship is likely to exist with relevant pollutant exposures, but important uncertainties remain. That is, the pollutant has been shown to result in health effects in studies in which chance and bias can be ruled out with reasonable confidence but potential issues remain. For example: a) observational studies show an association, but copollutant exposures are difficult to address and/or other lines of evidence (controlled human exposure, animal, or mode of action information) are limited or inconsistent; or b) animal toxicological evidence from multiple studies from different laboratories that demonstrate effects, but limited or no human data are available. Evidence generally includes multiple high-quality studies.
Suggestive of a causal relationship
Evidence is suggestive of a causal relationship with relevant pollutant exposures, but is limited. For example, (a) at least one high-quality epidemiologic study shows an association with a given health outcome but the results of other studies are inconsistent; or (b) a well-conducted toxicological study, such as those conducted in the National Toxicology Program (NTP), shows effects in animal species, Inadequate to infer a
Evidence is inadequate to determine that a causal relationship exists with relevant causal relationship pollutant exposures. The available studies are of insufficient quantity, quality, consistency, or statistical power to permit a conclusion regarding the presence or absence of an effect.
Not likely to be a
Evidence is suggestive of no causal relationship with relevant pollutant exposures.
causal relationship
Several adequate studies, covering the full range of levels of exposure that human beings are known to encounter and considering at-risk populations, are mutually consistent in not showing an effect at any level of exposure.
Source: U.S. EPA, 2013. 
California
Neighborhood-level poverty rate: 0-7%, 7-14%, 14-22%, 22-32%, ≥32%
Long-term; daily mean avged over pregnancy 23.5 (SD 6.5 ppb)
Birthweight
Quantitative results not given; in figure lower birth weights in association with change in ozone were observed in all grps except 0-7%. The change was not linear. At a fixed flow, absorbed fraction increased with penetration volume and elevating flow rate shifted the absorbed fraction distribution distally into the lungs so a greater amount of O3 reached the small airways and air spaces and less O3 was absorbed in the upper airways and conducting airways.
Study
Nodelman and Ultman PA, USA Adults, M/F, mean 24.7 20 ml bolus of 1.0 ppm O3 Absorbed fraction (amount of Larger penetrations of O3 beyond the 1999 ± 5.4 years old at respiratory flows of 150, O3 absorbed during a single upper airways occurred as flow increased 250, and 1000 ml/s respiratory cycle relative to inhaled amount), penetration volume (mean airway volume that would be reached by O3 molecules during inhalation if no absorption occurred) and during nasal than during oral breathing Obesity (genetic and diet induced) blunted the subacute (72 h) O3-induced decrease in Cdyn, increase in BALF macrophages and neutrophils, increase in BALF protein, and increase in BALF sTNFR1. IL-6 deficiency attenuated O3 induced increase in BALF macrophages and neutrophils. Obesity related difference in O3 inducted neutrophil influx was dependent on IL-6. Discordance with acute exposure, obesity increased acute (12-48 h) O3 induced increased BALF protein, BALF macrophages, and BALF sTNFR1. Diet Wagner et al. 2007 MI, USA Rat (Brown Norway), M 1.0 ppm with or without exposure to ovalbumin (days 1 and 2), 8 h/day, days 4 and 5, and γtocopherol on days 2-5 BALF cellularity, cytokine content, leukotriene content, tocopherols, intraepithelial mucosubstances morphometry, tissue eosinophil density
Ozone exposure of allergic rats enhanced intraepithelial mucosubstances increases in proximal axial airways (200%), induced cys-leukotrienes, MCP-1, and IL-6 production in BALF, and upregulated expression of IL-5 and IL-13 mRNA. Attenuated by γ-T treatment. Wagner et al. 2009 MI, USA Rat (Brown Norway), M 1.0 ppm with or without exposure to ovalbumin (days 1 and 2), 8 h/day, days 4 and 5, and γtocopherol on days 2-5
Nasal histology, morphology of intraepithelial mucosubstances, eosinophilic inflammation, mucin glycoprotein 5AC expression γ-tocopherol attenuated ozone+OVA increases in intraepithelial mucosubstances, mucosal eosinophils in nasal and paranasal airways, and MUC5AC expression. 
